Medical Economics February 1, 2024
Richard Payerchin

Administration, HHS tout milestone day on road to lowering drug prices for beneficiaries.

The United States is making an offer to Big Pharma on the 10 most commonly used drugs for Medicare.

Whether it’s an offer they can’t refuse remains to be seen.

On Feb. 1, the U.S. Centers for Medicare & Medicaid Services (CMS) will send initial offers to drug manufacturers on the first 10 drugs selected for negotiations to bring down prescription prices. “This is the first time ever that Medicare is not accepting the drug prices the pharmaceutical companies set,” said a statement from the White House.

In statements, President Joe Biden and the U.S. Department of Health and Human Services (HHS) touted Feb. 1, 2024, as...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, CMS, Govt Agencies, HHS, Insurance, Medicare, Pharma, Pharma / Biotech
109 hospitals receiving new Medicare-backed residency slots
Senators urge Congress to avert Medicare physician pay cut
Podcast: Medicare Shared Savings Program Mints $2B Win for Value-Based Care w/ Frank McStay
Medicare Part D in 2025: A First Look at Prescription Drug Plan Availability, Premiums, and Cost Sharing
Dr. Oz, RFK Jr. on Medicare, Medicaid: 10 notes

Share This Article